Post hoc analyses of SHIFT and PARADIGM‐HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: “Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial” by Bocchi et al.

Detalles Bibliográficos
Autores principales: Ramires, Felix J.A., Martinez, Felipe, Gómez, Efraín A., Demacq, Caroline, Gimpelewicz, Claudio R., Rouleau, Jean L., Solomon, Scott D., Swedberg, Karl, Zile, Michael R., Packer, Milton, McMurray, John J.V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300803/
https://www.ncbi.nlm.nih.gov/pubmed/30298996
http://dx.doi.org/10.1002/ehf2.12355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300803/
https://www.ncbi.nlm.nih.gov/pubmed/30298996
http://dx.doi.org/10.1002/ehf2.12355

Ejemplares similares